Recovery from renal failure in malignant hypertension associated with primary aldosteronism: Effect of an ACE inhibitor [4]

QJM: An International Journal of Medicine

Volumn 95, Issue 2, 2002, Pages 128-130

  Suzuki, H ^a   Asano, K ^a   Eiro, M ^a   Kuriki, M ^a   Hashimoto, S ^a   Katoh, T ^a   Watanabe, T ^a   Watanabe, K ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; IODINE 125; MANIDIPINE; NICARDIPINE; NIFEDIPINE; RENIN; SPIRONOLACTONE; TEMOCAPRIL;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ANAMNESIS; BLOOD PRESSURE MEASUREMENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MALIGNANT HYPERTENSION; POSTOPERATIVE PERIOD; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

EID: 0036185194     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Primary aldosteronism with malignant hypertension
2. Association of accelerated (malignant) hypertension in a patient with primary aldosteronism
3. Malignant hypertension: The role of the paracrine rennin-angiotensin system
4. Clinical implications of primary aldosteronism with resistant hypertension
5. Conn's syndrome can cause malignant hypertension
6. High rennin malignant hypertension secondary to an aldosterone-producing adenoma
7. Malignant hypertension in a patient with primary aldosteronism with elevated active rennin concentration
8. Complications and survival of 315 patients with malignant-phase hypertension